87 related articles for article (PubMed ID: 27096313)
1. CD5: A New Partner for IL-6.
Masuda K; Kishimoto T
Immunity; 2016 Apr; 44(4):720-2. PubMed ID: 27096313
[TBL] [Abstract][Full Text] [Related]
2. CD5 Binds to Interleukin-6 and Induces a Feed-Forward Loop with the Transcription Factor STAT3 in B Cells to Promote Cancer.
Zhang C; Xin H; Zhang W; Yazaki PJ; Zhang Z; Le K; Li W; Lee H; Kwak L; Forman S; Jove R; Yu H
Immunity; 2016 Apr; 44(4):913-923. PubMed ID: 27096320
[TBL] [Abstract][Full Text] [Related]
3. CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation.
Garaud S; Morva A; Lemoine S; Hillion S; Bordron A; Pers JO; Berthou C; Mageed RA; Renaudineau Y; Youinou P
J Immunol; 2011 Apr; 186(8):4835-44. PubMed ID: 21398617
[TBL] [Abstract][Full Text] [Related]
4. The activity of JAK-STAT pathways in rheumatoid arthritis: constitutive activation of STAT3 correlates with interleukin 6 levels.
Isomäki P; Junttila I; Vidqvist KL; Korpela M; Silvennoinen O
Rheumatology (Oxford); 2015 Jun; 54(6):1103-13. PubMed ID: 25406356
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid inhibits IL-6-dependent but not constitutive STAT3 activation in Epstein-Barr virus-immortalized B lymphocytes.
Zancai P; Cariati R; Quaia M; Guidoboni M; Rizzo S; Boiocchi M; Dolcetti R
Int J Oncol; 2004 Aug; 25(2):345-55. PubMed ID: 15254731
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
[TBL] [Abstract][Full Text] [Related]
7. Trans-signaling of interleukin-6 (IL-6) is mediated by the soluble IL-6 receptor, but not by soluble CD5.
Aparicio-Siegmund S; Deseke M; Lickert A; Garbers C
Biochem Biophys Res Commun; 2017 Mar; 484(4):808-812. PubMed ID: 28159554
[TBL] [Abstract][Full Text] [Related]
8. Model-driven experimental analysis of the function of SHP-2 in IL-6-induced Jak/STAT signaling.
Dittrich A; Quaiser T; Khouri C; Görtz D; Mönnigmann M; Schaper F
Mol Biosyst; 2012 Aug; 8(8):2119-34. PubMed ID: 22711165
[TBL] [Abstract][Full Text] [Related]
9. The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition.
Garbers C; Aparicio-Siegmund S; Rose-John S
Curr Opin Immunol; 2015 Jun; 34():75-82. PubMed ID: 25749511
[TBL] [Abstract][Full Text] [Related]
10. Janus kinase-signal transducer and activator of transcription mediates phosphatidic acid-induced interleukin (IL)-1beta and IL-6 production.
Lee C; Lim HK; Sakong J; Lee YS; Kim JR; Baek SH
Mol Pharmacol; 2006 Mar; 69(3):1041-7. PubMed ID: 16354768
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 trans-signalling induces vascular endothelial growth factor synthesis partly via Janus kinases-STAT3 pathway in human mesothelial cells.
Yang X; Lin A; Jiang N; Yan H; Ni Z; Qian J; Fang W
Nephrology (Carlton); 2017 Feb; 22(2):150-158. PubMed ID: 26869278
[TBL] [Abstract][Full Text] [Related]
12. IL-21 enhances the activity of the TLR-MyD88-STAT3 pathway but not the classical TLR-MyD88-NF-κB pathway in human B cells to boost antibody production.
Liu BS; Stoop JN; Huizinga TW; Toes RE
J Immunol; 2013 Oct; 191(8):4086-94. PubMed ID: 24043893
[TBL] [Abstract][Full Text] [Related]
13. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
14. The cell-cell interaction between tumor-associated macrophages and small cell lung cancer cells is involved in tumor progression via STAT3 activation.
Iriki T; Ohnishi K; Fujiwara Y; Horlad H; Saito Y; Pan C; Ikeda K; Mori T; Suzuki M; Ichiyasu H; Kohrogi H; Takeya M; Komohara Y
Lung Cancer; 2017 Apr; 106():22-32. PubMed ID: 28285690
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-10 attenuates tumour growth by inhibiting interleukin-6/signal transducer and activator of transcription 3 signalling in myeloid-derived suppressor cells.
Lee BR; Kwon BE; Hong EH; Shim A; Song JH; Kim HM; Chang SY; Kim YJ; Kweon MN; Youn JI; Ko HJ
Cancer Lett; 2016 Oct; 381(1):156-64. PubMed ID: 27431309
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 signal transduction and lymphocyte function.
Horn F; Henze C; Heidrich K
Immunobiology; 2000 Aug; 202(2):151-67. PubMed ID: 10993289
[TBL] [Abstract][Full Text] [Related]
17. STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria.
Samavati L; Rastogi R; Du W; Hüttemann M; Fite A; Franchi L
Mol Immunol; 2009 May; 46(8-9):1867-77. PubMed ID: 19299019
[TBL] [Abstract][Full Text] [Related]
18. 15-Deoxy-delta12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes.
Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon H; Um JW; Sohn J; Song GG; Ji JD
Exp Mol Med; 2005 Jun; 37(3):179-85. PubMed ID: 16000871
[TBL] [Abstract][Full Text] [Related]
19. Teleost IL-6 promotes antibody production through STAT3 signaling via IL-6R and gp130.
Kaneda M; Odaka T; Suetake H; Tahara D; Miyadai T
Dev Comp Immunol; 2012 Oct; 38(2):224-31. PubMed ID: 22469658
[TBL] [Abstract][Full Text] [Related]
20. Activation of the B-cell receptor successively activates NF-κB and STAT3 in chronic lymphocytic leukemia cells.
Rozovski U; Harris DM; Li P; Liu Z; Jain P; Veletic I; Ferrajoli A; Burger J; Thompson P; Jain N; Wierda W; Keating MJ; Estrov Z
Int J Cancer; 2017 Nov; 141(10):2076-2081. PubMed ID: 28722170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
